Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $58.09 +0.99%
Revenue Growth %: -4.6%
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: -4.6%
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.83, $0.01 better than the analyst estimate of $1.82. Revenue for the quarter came in at $12 billion versus the consensus estimate of $12.12 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2022 EPS of $7.65-$7.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Doximity downgraded by BofA on AI investment concerns, margin pressure
- DA Davidson flags Duolingo DAU momentum stalling, keeps Neutral at $120
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
